105 related articles for article (PubMed ID: 24571118)
1. NKX2-5, SIL/TAL and TLX3/HOX11L2 expression in Egyptian pediatric T-cell acute lymphoblastic leukemia.
Moussa H; Sidhom I
Asia Pac J Clin Oncol; 2016 Mar; 12(1):e1-10. PubMed ID: 24571118
[TBL] [Abstract][Full Text] [Related]
2. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951.
Cavé H; Suciu S; Preudhomme C; Poppe B; Robert A; Uyttebroeck A; Malet M; Boutard P; Benoit Y; Mauvieux L; Lutz P; Méchinaud F; Grardel N; Mazingue F; Dupont M; Margueritte G; Pages MP; Bertrand Y; Plouvier E; Brunie G; Bastard C; Plantaz D; Vande Velde I; Hagemeijer A; Speleman F; Lessard M; Otten J; Vilmer E; Dastugue N;
Blood; 2004 Jan; 103(2):442-50. PubMed ID: 14504110
[TBL] [Abstract][Full Text] [Related]
4. Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1.
Nagel S; Scherr M; Kel A; Hornischer K; Crawford GE; Kaufmann M; Meyer C; Drexler HG; MacLeod RA
Cancer Res; 2007 Feb; 67(4):1461-71. PubMed ID: 17308084
[TBL] [Abstract][Full Text] [Related]
5. Two dual-color split signal fluorescence in situ hybridization assays to detect t(5;14) involving HOX11L2 or CSX in T-cell acute lymphoblastic leukemia.
van Zutven LJ; Velthuizen SC; Wolvers-Tettero IL; van Dongen JJ; Poulsen TS; MacLeod RA; Beverloo HB; Langerak AW
Haematologica; 2004 Jun; 89(6):671-8. PubMed ID: 15194534
[TBL] [Abstract][Full Text] [Related]
6. Significance of HOX11L2/TLX3 expression in children with T-cell acute lymphoblastic leukemia treated on Children's Cancer Group protocols.
Gottardo NG; Jacoby PA; Sather HN; Reaman GH; Baker DL; Kees UR
Leukemia; 2005 Sep; 19(9):1705-8. PubMed ID: 15990867
[No Abstract] [Full Text] [Related]
7. HOX11L2 expression defines a clinical subtype of pediatric T-ALL associated with poor prognosis.
Ballerini P; Blaise A; Busson-Le Coniat M; Su XY; Zucman-Rossi J; Adam M; van den Akker J; Perot C; Pellegrino B; Landman-Parker J; Douay L; Berger R; Bernard OA
Blood; 2002 Aug; 100(3):991-7. PubMed ID: 12130513
[TBL] [Abstract][Full Text] [Related]
8. Prognostic relevance of TLX3 (HOX11L2) expression in childhood T-cell acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Münster (BFM) protocols containing early and late re-intensification elements.
Attarbaschi A; Pisecker M; Inthal A; Mann G; Janousek D; Dworzak M; Pötschger U; Ullmann R; Schrappe M; Gadner H; Haas OA; Panzer-Grümayer R; Strehl S;
Br J Haematol; 2010 Jan; 148(2):293-300. PubMed ID: 19821827
[TBL] [Abstract][Full Text] [Related]
9. t(5;14)/HOX11L2-positive T-cell acute lymphoblastic leukemia. A collaborative study of the Groupe Français de Cytogénétique Hématologique (GFCH).
Berger R; Dastugue N; Busson M; Van Den Akker J; Pérot C; Ballerini P; Hagemeijer A; Michaux L; Charrin C; Pages MP; Mugneret F; Andrieux J; Talmant P; Hélias C; Mauvieux L; Lafage-Pochitaloff M; Mozziconacci MJ; Cornillet-Lefebvre P; Radford I; Asnafi V; Bilhou-Nabera C; Nguyen Khac F; Léonard C; Speleman F; Poppe B; Bastard C; Taviaux S; Quilichini B; Herens C; Grégoire MJ; Cavé H; Bernard OA;
Leukemia; 2003 Sep; 17(9):1851-7. PubMed ID: 12970786
[TBL] [Abstract][Full Text] [Related]
10. Various types of rearrangements target TLX3 locus in T-cell acute lymphoblastic leukemia.
Su XY; Busson M; Della Valle V; Ballerini P; Dastugue N; Talmant P; Ferrando AA; Baudry-Bluteau D; Romana S; Berger R; Bernard OA
Genes Chromosomes Cancer; 2004 Nov; 41(3):243-9. PubMed ID: 15334547
[TBL] [Abstract][Full Text] [Related]
11. SIL-TAL1 fusion gene negative impact in T-cell acute lymphoblastic leukemia outcome.
Mansur MB; Emerenciano M; Brewer L; Sant'Ana M; Mendonça N; Thuler LC; Koifman S; Pombo-de-Oliveira MS
Leuk Lymphoma; 2009 Aug; 50(8):1318-25. PubMed ID: 19562638
[TBL] [Abstract][Full Text] [Related]
12. The cardiac homeobox gene NKX2-5 is deregulated by juxtaposition with BCL11B in pediatric T-ALL cell lines via a novel t(5;14)(q35.1;q32.2).
Nagel S; Kaufmann M; Drexler HG; MacLeod RA
Cancer Res; 2003 Sep; 63(17):5329-34. PubMed ID: 14500364
[TBL] [Abstract][Full Text] [Related]
13. [HOX11L2 expression and its clinical significance in paraffin-embedded T-lymphoblastic lymphoma].
Pan Y; Li GD; Liu WP; Zhou Q; Zhang WY
Zhonghua Xue Ye Xue Za Zhi; 2005 Oct; 26(10):585-8. PubMed ID: 16532965
[TBL] [Abstract][Full Text] [Related]
14. Immunophenotyping with CD135 and CD117 predicts the FLT3, IL-7R and TLX3 gene mutations in childhood T-cell acute leukemia.
Noronha EP; Andrade FG; Zampier C; de Andrade CF; Terra-Granado E; Pombo-de-Oliveira MS;
Blood Cells Mol Dis; 2016 Mar; 57():74-80. PubMed ID: 26852660
[TBL] [Abstract][Full Text] [Related]
15. The effect of a novel recombination between the homeobox gene NKX2-5 and the TRD locus in T-cell acute lymphoblastic leukemia on activation of the NKX2-5 gene.
Przybylski GK; Dik WA; Grabarczyk P; Wanzeck J; Chudobska P; Jankowski K; von Bergh A; van Dongen JJ; Schmidt CA; Langerak AW
Haematologica; 2006 Mar; 91(3):317-21. PubMed ID: 16531254
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of a new recombination of the SIL/TAL-1 locus in a child with T-cell acute lymphoblastic leukaemia.
Carlotti E; Pettenella F; Amaru R; Slater S; Lister TA; Barbui T; Basso G; Cazzaniga G; Rambaldi A; Biondi A
Br J Haematol; 2002 Sep; 118(4):1011-8. PubMed ID: 12199779
[TBL] [Abstract][Full Text] [Related]
17. Does TAL-1 deletion contribute to the high incidence of T-cell acute lymphoblastic leukemia in South Indian patients?
Sudhakar N; Nirmala K; Rajalekshmy KR; Rajkumar T
Asian Pac J Cancer Prev; 2008; 9(1):127-30. PubMed ID: 18439091
[TBL] [Abstract][Full Text] [Related]
18. MYB rearrangements and over-expression in T-cell acute lymphoblastic leukemia.
Bardelli V; Arniani S; Pierini V; Pierini T; Di Giacomo D; Gorello P; Moretti M; Pellanera F; Elia L; Vitale A; Storlazzi CT; Tolomeo D; Mastrodicasa E; Caniglia M; Chiaretti S; Ruggeri L; Roti G; Schwab C; Harrison CJ; Almeida A; Pieters T; Van Vlierberghe P; Mecucci C; La Starza R
Genes Chromosomes Cancer; 2021 Jul; 60(7):482-488. PubMed ID: 33611795
[TBL] [Abstract][Full Text] [Related]
19. The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocols.
van Grotel M; Meijerink JP; Beverloo HB; Langerak AW; Buys-Gladdines JG; Schneider P; Poulsen TS; den Boer ML; Horstmann M; Kamps WA; Veerman AJ; van Wering ER; van Noesel MM; Pieters R
Haematologica; 2006 Sep; 91(9):1212-21. PubMed ID: 16956820
[TBL] [Abstract][Full Text] [Related]
20. Clinical and biological relevance of genetic alterations in pediatric T-cell acute lymphoblastic leukemia in Taiwan.
Yeh TC; Liang DC; Liu HC; Jaing TH; Chen SH; Hou JY; Yang CP; Huang YJ; Yao HW; Huang TY; Lin TH; Shih LY
Pediatr Blood Cancer; 2019 Jan; 66(1):e27496. PubMed ID: 30280491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
